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To compile a list of genes that have been reported to be affected by external ionizing radia-
tion (IR) and to assess their performance as candidate biomarkers for individual human radi-
ation dosimetry.
Methods
Eligible studies were identified through extensive searches of the online databases from
1978 to 2017. Original English-language publications of microarray studies assessing radia-
tion-induced changes in gene expression levels in human blood after external IR were
included. Genes identified in at least half of the selected studies were retained for bio-statis-
tical analysis in order to evaluate their diagnostic ability.
Results
24 studies met the criteria and were included in this study. Radiation-induced expression of
10,170 unique genes was identified and the 31 genes that have been identified in at least
50% of studies (12/24 studies) were selected for diagnostic power analysis. Twenty-seven
genes showed a significant Spearman’s correlation with radiation dose. Individually,
TNFSF4, FDXR, MYC, ZMAT3 and GADD45A provided the best discrimination of radiation
dose < 2 Gy and dose 2 Gy according to according to their maximized Youden’s index
(0.67, 0.55, 0.55, 0.55 and 0.53 respectively). Moreover, 12 combinations of three genes
display an area under the Receiver Operating Curve (ROC) curve (AUC) = 1 reinforcing the
concept of biomarker combinations instead of looking for an ideal and unique biomarker.
Conclusion
Gene expression is a promising approach for radiation dosimetry assessment. A list of
robust candidate biomarkers has been identified from analysis of the studies published to
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date, confirming for example the potential of well-known genes such as FDXR and TNFSF4
or highlighting other promising gene such as ZMAT3. However, heterogeneity in protocols
and analysis methods will require additional studies to confirm these results.
Introduction
A mass-casualty nuclear disaster, such as detonation of a terrorist dirty bomb or a nuclear
power plant incident, requires an effective and fast planning for the medical response in order
to treat and save thousands of lives. As such, there is a need to assess precisely the absorbed
radiation dose for setting an effective triage of the affected population in order to distinguish
those who need immediate medical intervention from those who are candidates for delayed
treatment [1].
Professional radiation workers, astronauts or even patients wear a radiation detector, which
can use a wide range of different physical and chemical interactions to convert dose to a
directly measurable quantity, such as electronic charge collected from air ionization or color
change arising from changes in atomic electronic states [2]. However, in the event of a radio-
logical catastrophe, as the general population is not so equipped, dosimetry assessment cannot
be performed with radiation detectors. Instead, it would be accomplished through a combina-
tion of physical dosimetry, history of an individual’s location, clinical signs and symptoms,
and individual hematology assessment, with other methods such as the dicentric chromosome
assay (DCA) used for long-term risk assessment [1].
Sullivan et al. detailed the different biological approaches for radiation dose assessment
including DCA, gamma-H2AX foci assay, cytokinesis block micronucleus assay or “-omic”
assays [1]. Although there is no biodosimetry method approved by the U.S. Food and Drug
Administration (FDA) yet, the DCA is currently considered the “gold-standard”. This assay is
very specific to IR and low background levels of dicentric chromosomes allow it to be highly
sensitive. However, like all cytogenetics-based assays, the DCA is labor intensive and takes a
long time to estimate the dose, an important limitation for radiation dose assessment in an
emergency scenario. Indeed, early medical intervention has been shown to improve the sur-
vival of individuals after radiation exposure and some medical countermeasures are most
effective when administered within the first 24 hours [1]. Alternative methods, such as the
gamma-H2AX foci assay, electron paramagnetic resonance, or automation of pre-existing
approaches are faster but require cost-intensive machines and large facilities [3–5].
The development of gene expression profiles, especially in peripheral blood lymphocytes,
has been suggested as an alternate approach to radiation biodosimetry [6,7]. Exposure of
human cells to environmental stresses, including IR, is known to activate multiple signal trans-
duction pathways, and rapidly results in complex patterns of gene expression change. In con-
trast to DCA or the micronucleus assay, gene expression does not require cell division and can
be analyzed quickly with advanced molecular assays. Moreover, recent improvements in
microfluidics and “lab-on-chip” technology, may enable automation and miniaturization to
provide a point-of-care device integrated in a high-throughput platform able to process and
analyze large numbers of samples and return results in a few hours [8].
Several large-scale studies have investigated gene expression levels after irradiation. How-
ever, there is often a large discrepancy in the identified biomarkers and the reproducibility of
results is unclear. The reasons for the observed variability may include different microarray
platforms, variations in experimental protocols, and dissimilar statistical approaches.
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The purpose of this paper was to conduct a systematic review of the scientific literature to
compile a list of genes that have been reported to be affected by external ionizing radiation and
to use their response level to assess them as candidates for individual human biodosimetry
after IR exposure across the published studies. Blood is a preferred tissue for radiation biodosi-
metry both because white cells are highly radiation sensitive and show robust responses, and
because collection is minimally invasive and can be performed in non-clinical settings [9]. As
the great majority of gene expression biodosimetry studies have been performed using blood
or blood cells, we focused our analysis on this model. Moreover, in order to avoid an “a-priori”
selection, we focused our analysis on studies that did not use a candidate gene approach but
performed large-scale screening to identify radiation-induced gene expression changes.
Material and methods
Literature search
We identified relevant studies using MEDLINE (1978–2017) and EMBASE (1990–2017) data-
bases using the following search terms: (“gene expression signature”[All Fields] OR “gene expres-
sion”[All Fields] OR “gene expression changes”[All Fields] OR “transcription response”[All
Fields]) AND (“radiation exposure”[All Fields] OR “ionizing radiation” [All Fields] OR “radio-
therapy”[All fields]) AND (“human peripheral blood”[All Fields] OR “human blood”[All Fields]
OR “blood cells”[All Fields] OR “human cells”[All Fields]) AND/OR (“microarray” [All Fields]).
The search was conducted based on the Preferred Reporting Items for Systematic Reviews and
Meta-analysis (PRISMA) guidelines [10] (S1 PRISMA Checklist). Two authors (JL and FZ)
independently screened the titles and abstracts, with disagreements resolved by iteration and
consensus. Where the suitability of the article was uncertain, the full text was assessed.
Study eligibility
Papers were retained if they reported any large-scale approach (qRT-PCR has been excluded)
to measure gene expression changes in human blood after external photonic ionizing radiation
(ex-vivo or in-vivo). Studies on animal, plant or human cell lines were excluded as well as stud-
ies that investigated effects of ultraviolet radiation, electromagnetic field, internal emitters or
particle radiation. Only studies published in English in peer-reviewed journals were included.
Entries of review articles, conference abstracts, book chapters, editorials, or commentaries
were excluded. We also excluded papers that did not provide a full list of radiation-modified
gene expression with fold change and p-value, either in supplementary data or database. Refer-
ences from selected articles were also reviewed to ensure the inclusion of all relevant articles.
Quality assessment and data extraction
Data extraction was performed using a standardised data extraction form (S1 File). We addi-
tionally used the Guidelines for the REporting of Tumor MARKer Studies (REMARK) to rank
the selected publications and identified potential bias [11] (see S2 File for a detailed REMARK
checklist). Because REMARK was created for oncology studies, we modified the criteria to
enable use for radiation dosimetry studies. A collection of these modified REMARK (mRE-
MARK) scores were then collated and ranked. REMARK scores between 15 and 20 were con-
sidered reflective of a higher quality study, with very low risk of bias. Studies with REMARK
scores between 8 and 15 were considered to have a moderate risk of bias while those with
REMARK scores below 8 were considered to have a high risk of bias and have been excluded
from the analysis. Genes that have been reported in at least 50% of the selected studies (12
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studies of 24) and whose expression is significantly altered (p<0.05) for at least one radiation
dose and one time point have been included in this study.
Statistics
A database has been created from raw data. For studies that did not provided fold changes for
all gene, fold changes were calculated using the R package limma [12], after the raw data was
normalized using loess normalization within the array and quantile normalization between
the arrays. The Spearman’s rank correlation coefficient was used to assess dose dependence of
the gene expression levels and test performance across all the studies. The individual gene bio-
markers performance is based on Receiver Operating Characteristic (ROC) curves, which
allow the characterization of the discrimination between two well-defined populations. The
sensitivity, specificity, positive and negative predictive values of each gene were evaluated
using the optimal threshold value calculated to maximize the Youden’s index. This index is
defined as the sum of the sensitivity and specificity (expressed by a number comprised between
0 and 1) minus 1. All differences were considered statistically significant when p< 0.05. Anal-
yses were performed with GraphPad Prism version 7.00 for Windows (GraphPad Software
Inc., La Jolla, CA).
Additionally, the selected candidate genes were considered as the seed molecules from
which we obtained direct and indirect protein-protein interactions using the STRING 10.5
database (Search Tool for the Retrieval of Interacting Genes) [13]. This database provides
information on both experimental and predicted interactions from varied sources based on
their neighborhood, gene fusions, co-occurrence, co-expression, experiments and literature
mining. Additionally, the p53FamilyTargetGenes database (p53FamTaG), a comprehensive
and reliable resource of genome-wide search of human p53, p63 and p73 direct target genes
combining in silico prediction of p53 responsive elements (p53REs) has been used to identify
p53 target genes [14].
Results
Literature search
As shown in Fig 1, the initial search revealed a total of 2313 studies. After removing duplicates
(n = 458), 1855 unique records were screened. After removing non-research articles and
research papers that do not investigated effect of external photonic ionizing radiation on
human blood tissue, 148 full-text articles were assessed for eligibility. Among these articles, we
excluded 107 studies that did not use a large-scale approach or did not assess gene expression
level. We also excluded 17 additional studies that did not provide full lists of gene expression
changes with fold change and p-value of candidate genes or that provided unclear data analysis
and insufficient details about presented results. Finally, data were extracted from 24 articles.
Study characteristics and risk of bias
The characteristics of these 24 included studies are detailed in Table 1. Using the modified
REMARK checklist to assess the risk of bias in the included studies, we found 7 with a low risk
and 16 studies with a moderate risk. According to our criteria, one study has been found with
a high risk [15] (S1 Table). However, this paper has not been excluded because it is a data
paper and therefore, its low score is mainly due to the lack of data analysis and interpretation.
Most studies assessed the effects of gamma and X-ray irradiation on blood tissue from
healthy individuals after ex-vivo irradiation. However, five of the studies, assessed gene expres-
sion change after total body irradiation (TBI), and therefore, recruited patients and not healthy
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individuals. The combined population of the twenty-four studies totaled 264 participants.
Total sample size ranged from 45 to 386 patients. The median number of participants per
study was 8 (range 3 to 27). In addition, Vinoth et al. [16] does not specify the number of par-
ticipants and so, these have not been taken included in these numbers. The primary goal of
two studies was not to investigate biodosimetry but to predict radiotoxicity [17,18]. However,
these studies filled all our criteria as they assessed gene expression changes in blood by using a
microarray approach after irradiation and therefore have been retained. All together, these
studies investigated a large range of dose (from 0.005 to 60 Gy), dose-rate (from 3.1 mGy/min
to 7.6 Gy/min) and time of analysis after irradiation (from 30 min to 48 h); however, radia-
tion-induced responses are extremely time- and dose-dependent. Nevertheless, we did not
restrain our study to a more specific time or dose range because of our desire to identify a
unique biomarker signature able to discriminate any radiation dose exposure after any time.
The sample preparation also differs widely, either in the type of irradiated samples, the source
of RNA used, or the microarray platform. Indeed, most studies performed an ex-vivo
Fig 1. Flow diagram outlining the selection procedure to identify 24 articles that were included in the systematic review of gene radiation dosimetry biomarkers
in human blood.
https://doi.org/10.1371/journal.pone.0198851.g001
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irradiation directly on anticoagulated whole blood (WB) or after isolating peripheral blood
mononuclear cells (PBMCs). Only five studies used in vivo irradiation, collecting blood samples
from patients during the course of TBI. In the same way, some studies analyzed radiation-
induced gene expression changes in WB (that included all white blood cells such as mononu-
clear and polynuclear cells) whereas other studies used a post-irradiation density gradient to
select PBMCs and then analyzed changes only in this population. Although it appears that radi-
ation induced gene expression may vary among lymphocyte subsets [19], there is a high degree
of overlap in radiation responsive genes detected in peripheral blood and in isolated PBMCs
[20]. Based on this, we have included studies using both WB and isolated PBMC in our analysis.
Reported radiation dosimetry biomarkers and diagnostic ability
All together, these studies identified more than 10,000 unique genes with significant radiation-
induced changes of expression level for at least one radiation dose. Among these, 41.9% are
down-regulated and 58.1% up-regulated (S2 Table).
Biomarkers identified in only one microarray dataset are usually irreproducible across stud-
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this review to select for analysis the genes whose expression was significantly altered after at
least one radiation dose in at least 50% of studies (12 studies of 24). We list the 31 genes that
have met these criteria in Table 2.
DDB2 and PCNA are the genes both identified by the most studies (20/24) whereas
FBXO22, PLK2, TIGAR, TNFSF4 and ZNF49 have only been found in thirteen studies. Inter-
estingly, 97% of these genes (30/31) are up-regulated after IR and only the MYC gene is down-
regulated. Not surprisingly, the enrichment analysis for Gene Ontologies shows that majority
of these genes are involved in cellular responses to stress such as radiation, DNA damage stim-
ulus, UV, etc. (S3 Table). The majority of these genes (27/31) are known to be directly regu-
lated by p53, meaning these genes contain response elements (RE) that are recognized by
sequence-specific nuclear transcription factors encoding by p53. However, although AEN,
TIGAR, TRIAP and ZMAT3 are not identified as having classic p53 RE, they are known to be
p53 inducible [41–44]. Moreover, the extended protein-protein interaction network generated
using the 31 seed genes in STRING resulted in 51 interactions, whereas only 12 interactions
were expected (Fig 2). This means that there are more interactions among the proteins than
what would be expected for a random set of seed genes of similar size, suggesting that the enti-
ties are at least partially biologically connected, as a group.
In order to select genes that could be good candidate radiation dosimetry biomarkers, we
calculated the Spearman’s rank correlation coefficient by using the radiation dose and fold
change from the raw data of the different included studies. For this, we decided to focus on
radiation doses between 1 and 8 Gy. Human acute radiation syndrome (ARS) manifests fol-
lowing whole-body or partial-body irradiation in humans at estimated radiation doses gener-
ally above 1 Gy and delivered at relatively high dose rates. Individuals receiving doses< 1 Gy
may still require medical management and treatment for symptoms, but delay of treatment
could be considered since the level of exposure is not expected to pose immediate danger to
life, allowing for judicious use of scarce resources in a radiation mass casualty incident. The
LD50 (50% lethal dose) radiation dose for humans is estimated between 3.5 and 4.5 Gy but
with increasing levels and qualities of supportive care, the estimated range of the LD50 values
increases to 6–8 Gy with clinically unmanageable gastrointestinal syndrome dominating above
8–10 Gy. As the current strategies for mitigation are focused on the hematopoietic syndrome,
we decided to exclude from the statistical analysis all data points with a dose > 8 Gy. Results
showed that the expression of 27/31 genes is significantly correlated to the radiation dose
within the 1–8 Gy range (S1 Fig). Only EI24, BBC3, BAX and TIGAR do not display a signifi-
cant correlation with the radiation dose. TNSF4 has the highest Spearman’s rank correlation
coefficient (r = 0.73). The majority of genes showed a significant increasing monotonic trend
between their expression and the radiation dose, while the MYC gene showed a decreasing
monotonic trend (Table 3).
In a case of radiological incident, the technical requirements for initial triage include that it
be accurate enough to identify anyone with a dose above 2 Gy for consideration of urgent
treatment for ARS (although this 2 Gy threshold might vary to fit special populations, injured
individuals or available resources) [45]. Therefore, in order to assess the diagnostic ability of
the selected genes, we performed ROC curve analysis to discriminate radiation doses below 2
Gy from doses equal to or above 2 Gy as shown in S2 Fig. Candidate genes are able to discrimi-
nate these two groups with AUCs ranging from 0.507 (TIGAR) to 0.860 (TNFSF4) (Table 4).
Only CD70 gene show a specificity of 100% for a sensitivity of 52%. Among the five genes with
the highest Youden’s index (TNFSF4, FDXR, MYC, ZMAT3 and GADD45A), all of them dis-
play at least a sensitivity superior to 55% and a specificity superior to 80%. It is interesting to
note that TNFSF4 which has the highest Youden’s index (0.67) is also the one with the highest
Spearman’s rank correlation coefficient.
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Table 2. Characteristics of the 31 selected genes.
Gene
Symbol






ACTA2 actin, alpha 2, smooth
muscle, aorta











ATP binding Y (2) " 17 [18,20–22,24–26,28–36,38]
BAX BCL2 associated X,
apoptosis regulator
apoptosis chaperone binding Y (3) " 20 [16,18,20–24,26–38]
BBC3 BCL2 binding component 3 apoptosis protein binding Y (2) " 17 [20–23,26–38]
CCNG1 cyclin G1 cell cycle regulation cyclin Y (3) " 17 [16,18,20,22,24–26,28,29,31–
38]
CD70 CD70 molecule apoptosis, cell-cell
signaling
receptor binding Y (1) " 15 [16,20,22,24,26,28,29,31–38]
CDKN1A cyclin dependent kinase
inhibitor 1A
cell cycle arrest, DNA
damage response,
apoptosis
cyclin binding Y (7) " 17 [16–18,20–24,26,28,29,32–37]
DDB2 damage specific DNA
binding protein 2
DNA repair DNA binding Y (11) " 21 [17,18,20–26,28–39]
EI24 EI24, autophagy associated
transmembrane protein
apoptosis, autophagy p53 binding Y (5) " 14 [18,20,21,25,26,28–34,36,39]




Y (9) " 13 [16,18,20,24,26,28,29,31–36]




Y (3) " 16 [18,20–22,24,26,27,29,31–38]




kinase binding Y (1) " 17 [16,18,20,22–24,26,28–37]
IER5 immediate early response 5 cell proliferation,
response to heat
protein binding Y (1) " 16 [16–18,21,22,26–29,31–37]








cell cycle arrest DNA binding Y (2) # 16 [20–24,26,28,29,31–37,39]






Y (1) " 21 [15,17,18,20–24,26–38]
PHPT1 phosphohistidine
phosphatase 1
cell metabolism ion channel binding Y (1) " 14 [18,20–22,24,26,28,29,31–
35,37]
PLK2 polo like kinase 2 DNA damage response ATP binding, signal
transducer activity
Y (3) " 13 [17,20–22,26,28,29,32–37]
POLH polymerase (DNA) eta DNA repair DNA binding Y (3) " 15 [18,20,22,24–26,28,29,31–
35,37,38]
RPS27L ribosomal protein S27 like DNA repair, apoptosis RNA binding Y (1) " 17 [15,18,20–24,26–29,31–36]




Y (4) " 18 [16,18,20–26,28–30,32–37]
TIGAR$ TP53 induced glycolysis
regulatory phosphatase






protein binding Y (3) " 16 [17,20,22–24,26,28–37]




receptor activity Y (8) " 17 [16,18,20–22,24,26,27,29,31–
38]
TNFSF4 TNF superfamily member 4 immune response receptor binding Y (5) " 13 [18,20,22,25,26,29,32–38]
(Continued)
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As sampling time may play an important role in biodosimetry studies and in the perfor-
mance of potential biomarkers, we also performed an additional analysis comparing gene per-
formance between early time ( 6 hours) and long time ( 24 hours) after irradiation by
using spearman’s rank correlation coefficient (S4 Table) and AUC and diagnostic accuracies
(S5 Table). First, results showed that few genes (ZMAT3, TNFSF4 and TMEM30) are signifi-
cantly correlated to the radiation dose for time 6hours. Conversely, with the exception of
BAX, all the genes showed a significant monotonic trend between their expression and the
radiation dose for time 24 hours. Most of the included studies assessed gene expression for
late (or middle) time points and therefore, few data points are available for early timing points
and this can explain the poor significance for time 6 hours. However, these results showed
high disparity between genes. For example, PLK2 or IER5 display a good correlation with radi-
ation dose (r = 0.6041, p<0.0002 and r = 0.6881, p<0.0003 respectively) for time 24 hours
whereas there is no correlation with time 6 hours (r = 0.068, p = 0.87 and r = 0.2242,
p = 0.44 respectively). Conversely, although they do not display a significant correlation for
early time point, some genes seem to be more consistent with later time (ZMAT3, TNFSF4,
TMEM30A).
Interestingly, ROC curve analysis showed the same results profile with genes displaying a
lower diagnostic performance for early time points compared to late time points. Indeed,
twelve genes have Youden’s index 0.5 for time 6 hours whereas only two genes (TIGAR
and BAX) have a Youden’s index<0.5 for time 24 hours. Candidate genes are able to dis-
criminate dose 2 Gy and> 2 Gy with AUCs ranging from 0.514 (CD70) to 0.933 (ZMAT3)
for time 6 hours and with AUCs ranging from 0.613 (BAX) to 0.904 (TNFSF4) for time
24 hours.
In a case of accidental radiation exposure and population triage, the intent may be to mini-
mize misidentifying anyone as being below the threshold (‘false negative assignment’) so that
very few people who could benefit are overlooked for receiving treatment [45]. Therefore, we
calculated the diagnostic power of the 31 genes by setting a sensitivity of 100% in order to elim-
inate all false negatives (Table 5). Not surprisingly, the false positive rate increased drastically
as specificity decreased. Seventeen genes even showed a specificity of 0%. TNFSF4, ZNF79,
ZMAT3, FDXR and TMEM30A are the top 5 genes in this analysis and display specificity of
38, 24, 23, 17 and 14% respectively. With these settings, TNFSF4, FDXR and ZMAT3 are still














p53 binding N " 19 [16,18,20–24,26,28–38]
TRIM22 tripartite motif containing
22
immune response transcription factor
activity
Y (3) " 17 [18,20,22–26,26,29–34,36–38]
XPC XPC complex subunit,
DNA damage recognition
and repair factor
DNA repair DNA binding Y (5) " 18 [17,18,20,22–26,28–36,38]
ZMAT3 zinc finger matrin-type 3 apoptosis RNA binding N " 17 [16,20–24,26,27,29–36,38]
ZNF79 zinc finger protein 79 transcription DNA binding Y (3) " 13 [18,20,22,26,29,31–38]
N, No; REs, Response Elements; Y, Yes.
 alternative name: ISG20L1.
$ alternative name: C12orf5.
https://doi.org/10.1371/journal.pone.0198851.t002
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Fig 2. Protein-protein interaction enrichment network generated in STRING 10.5 using the 31 selected seed genes. The edges represent protein-protein association.
Blue and purple edges are known interactions (from curated databases and experimentally determined, respectively). Yellow and black edges are interactions derived
from text-mining and co-expression respectively. The green edge between AEN and PCNA is a predicted interaction as gene neighborhood.
https://doi.org/10.1371/journal.pone.0198851.g002
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sensitivity is fixed at 100% whereas they displayed bad performance compared to others genes
when diagnostic accuracy was calculated according to the maximized Youden’s index. This
suggests the interest of investigating an approach combining several biomarkers instead of
looking at individual candidate genes in order to increase both specificity and sensitivity.
Therefore, diagnostic power using gene combinations for these two groups was next
assessed by first fitting a multiple linear regression model, and as in the individual gene analy-
sis, plotting ROC curves and calculating AUCs using the model fitted values. When two genes
are combined, four combinations showed an AUC superior to 0.95 (IER5+ZMAT3, CCNG1+-
TNFSF4, TNFSF4+TRIM22, BAX+TNFSF4 and IER5+TNFSF4). All of them include ZMAT3
or TNFSF4 that are in the top 3 with best AUC as individual markers when sensitivity is fixed
at 100% (S3 Fig). However, the best combination of two genes for classification performance
was obtained with the association of IER5 and TNFSF4 that showed an AUC = 0.994 (Fig 3).
When three genes are combined, our statistical analysis showed that 12 combinations display
an AUC = 1 (S6 Table).
Table 3. Genes classified according to their Spearman’s rank correlation coefficient (r) and p-value between their
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Particle irradiation
We only selected for this work the studies that assessed gene expression changes after photon
irradiation (X-ray or γ-ray irradiation). However, in the case of a radiobiological event, irradia-
tion may be different and may involve particles such as neutrons, protons or alpha particles.
Therefore, there is also a need to identify radiation biomarkers for these specific types of irra-
diation. Although a few studies have assessed gene expression changes after particle irradiation
in whole blood, especially by using a microarray approach, we identified three studies during
our investigation that we report in Table 6. Unsurprisingly, many of the same genes respond
to both X rays and particles. Indeed, among the 33 genes differentially regulated by photon
irradiation, twenty-seven have also showed differential expression after particle irradiation in
at least 2 of the 3 studies reported in Table 6. Three genes (BBC3, CD70 and MDM2) are even
represented in all three studies. However, as raised by Broustas et al., the fold-change observed
in response to neutrons is generally greater than the same dose of X rays [22].
Table 4. AUC and diagnostic accuracies of the 33 genes discriminating radiation dose<2Gy and2Gy classified according to their maximized Youden’s index.
Gene AUC [95% CI] Sensitivity (%) Specificity (%) PPV (%) NPV (%) False positive (%) False negative (%) Youden’s index
TNFSF4 0.860, [0.75–0.97] 75 92 90 79 10 21 0.67
FDXR 0.742, [0.60–0.88] 75 80 69 85 31 15 0.55
MYC 0.678, [0.51–0.84] 60 95 94 68 6 32 0.55
ZMAT3 0.776, [0.64–0.91] 59 96 93 74 7 26 0.55
GADD45A 0.641, [0.49–0.79] 57 96 94 68 6 33 0.53
CD70 0.672, [0.52–0.83] 52 100 100 68 0 33 0.52
AEN 0.700, [0.55–0.85] 62 89 76 80 24 20 0.5
TNFRSF10B 0.650, [0.49–0.81] 73 75 62 83 38 17 0.48
ZNF79 0.734, [0.59–0.88] 60 88 83 69 17 31 0.48
PCNA 0.661, [0.52–0.80] 50 97 94 66 6 34 0.47
TRIAP1 0.648, [0.50–0.80] 57 90 85 68 15 33 0.47
TMEM30A 0.683, [0.54–0.83] 64 82 78 70 22 30 0.46
ACTA2 0.676, [0.52–0.83] 50 95 93 59 7 41 0.45
MDM2 0.684, [0.54–0.83] 52 93 88 65 12 35 0.45
PLK2 0.643, [0.48–0.81] 56 89 88 57 12 43 0.44
TRIM22 0.656, [0.49–0.82] 57 86 75 74 25 26 0.43
XPC 0.644, [0.50–0.79] 57 86 76 71 24 29 0.43
CCNG1 0.613, [0.45–0.77] 54 88 78 71 22 29 0.42
DDB2 0.610, [0.46–0.76] 47 95 88 69 12 31 0.42
PHPT1 0.592, [0.43–0.75] 61 81 74 70 26 30 0.42
RPS27L 0.591, [0.44–0.75] 59 82 74 70 26 30 0.41
ASCC3 0.636, [0.48–0.79] 52 88 82 64 18 36 0.4
IER5 0.628, [0.44–0.81] 68 72 75 65 25 35 0.4
CDKN1A 0.625, [0.47–0.78] 52 86 83 56 17 44 0.37
EI24 0.537, [0.35–0.73] 53 83 77 63 23 38 0.36
POLH 0.603, [0.45–0.75] 46 90 81 64 19 36 0.36
BBC3 0.572, [0.42–0.73] 56 79 68 68 32 32 0.34
FBXO22 0.627, [0.46–0.79] 62 70 73 58 27 42 0.32
SESN1 0.611, [0.45–0.77] 40 88 77 59 23 41 0.28
BAX 0.512, [0.36–0.66] 27 94 80 58 20 42 0.2
TIGAR 0.507, [0.32–0.69] 16 100 100 59 0 41 0.16
AUC: Area Under the Curve; CI: Confidence Interval; NPV: Negative Predictive Value; PPV: Positive Predictive Value
https://doi.org/10.1371/journal.pone.0198851.t004
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Mouse model
To evaluate radiation-induced changes of gene expression in humans, models are unfortu-
nately limited. We saw that most studies used ex-vivo irradiation as a source of radiation.
Obviously, this approach does not fit perfectly with the real situation encountered during an
accidental radiation exposure since the blood cells are not exposed to internal stress signals
that would be detected by circulating blood cells. Human in vivo radiation exposure may be
studied by collecting blood samples from patients that receive radiation treatment. However,
this model is still limited: patients are generally subjected to a fractionated radiation dose tar-
geted to the tumor, limiting the dose to the blood. In order to study a range of total absorbed
doses to the blood, it is thus necessary to collect samples after several fractions of treatment,
but gene expression may not then reflect the effect of a single high radiation dose like during
an acute accidental exposure event. Finally, there may be a lot of confounding factors as these
Table 5. Estimated specificity, positive predictive value rate, false positive and Youden’s index of the 33 genes discriminating radiation dose<2Gy and2Gy at
fixed sensitivity of 100%.
Gene Specificity (%) PPV (%) False positive (%) Youden’s index
TNFSF4 38 62 38 0.38
ZNF79 24 57 43 0.24
ZMAT3 23 52 48 0.23
FDXR 17 41 59 0.17
TMEM30A 14 54 46 0.14
SESN1 12 53 47 0.12
TRIM22 10 45 55 0.1
XPC 9 47 53 0.09
TNFRSF10B 8 37 63 0.08
AEN 7 39 61 0.07
POLH 7 50 50 0.07
ACTA2 5 58 42 0.05
FBXO22 5 58 42 0.05
CCNG1 3 45 55 0.03
ASCC3 0 49 51 0
BAX 0 48 52 0
BBC3 0 44 56 0
CD70 0 48 52 0
CDKN1A 0 58 42 0
DDB2 0 44 56 0
EI24 0 50 50 0
GADD45A 0 51 49 0
IER5 0 54 46 0
MDM2 0 50 50 0
MYC 0 52 48 0
PCNA 0 49 51 0
PHPT1 0 46 54 0
PLK2 0 59 41 0
RPS27L 0 45 55 0
TIGAR 0 44 56 0
TRIAP1 0 49 51 0
PPV: Positive Predictive Value
https://doi.org/10.1371/journal.pone.0198851.t005
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patients almost always receive other systemic treatments such as chemotherapy or immuno-
therapy, or even may develop radiotoxicity, that can also modify gene expression. Given these
constraints, the best human in vivo model is most likely patients undergoing total body irradi-
ation but these samples may still be difficult to access. Finally, cancer patients may not be an
appropriate model for the response of healthy individuals, as it is not fully understood how dif-
ferent disease states modify the baseline gene expression, or the radiation response.
For these reasons, much biodosimetry development has relied on animal models, especially
mice, to allow in vivo irradiation to be performed in a completely controlled environment.
However, nothing indicates that the gene radiation response will be identical in mouse com-
pared to the human body. During our literature search, we identified several studies investigat-
ing radiation-induced changes of gene expression in mouse blood (Table 7). All these studies
used C57BL/6 mice. We do not discuss the choice of this strain here, but it is important to
note that the primary radiation response to DNA damage is strain dependent [48]. As varia-
tions in individual radiosensitivity exist in human, such differences are also present between
mouse strains, highlighting the importance of population selection for experimental design.
For example, several studies have reported the number of gamma-H2AX foci in skin or in
blood lymphocytes following total body irradiation exposure differ and is higher in BALB/cJ
mice than C57BL/6J [49,50].
Interestingly, none of the mouse studies used an ex-vivo irradiation approach but rather
performed partial/total body irradiation or assessed the effect of an internal emitter, reflecting
the greater flexibility of mouse models for such investigations. Genes in the mouse blood show
a similar response to genes from human blood since 26 genes are in common with the 33
human genes panel identified in this study. These results indicate that the mouse model may
be useful in extrapolating to a human radiation response. However, dose-response is not
always correlated between species, probably due to some species-specific metabolism or to dif-
ferences in experiment configuration (in vivo vs. ex vivo). Beyond the mouse model, and in
order to be phylogenetically closer to human biology, a recent study used a non-human pri-
mate (NHP) model to compare the gene expression response with ex-vivo human blood
exposed to a broad range of radiation doses [51]. The authors showed that a robust NHP
Fig 3. Receiver operating characteristic (ROC) curve analysis of IER5 + TNFSF4 combination that displays area under
the ROC curve (AUC) 0.99 to discriminate radiation dose< 2 Gy from radiation dose 2 Gy.
https://doi.org/10.1371/journal.pone.0198851.g003
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biodosimetry model can be built using interspecies-correlated genes, and that, by using multi-
ple regression-based cross-species conversion of expression values, absorbed dose in human
samples can be accurately predicted by the NHP model.
Discussion
Many studies have been performed using large-scale approaches to investigate radiation blood
response and identify dosimetry biomarkers. However, due to complex logistics, these studies
are limited either by the number of patients or by the number of different timing points or
radiation doses, thus providing few data points for relevant direct comparisons. According to
our selection criteria, we compiled in this systematic review 24 microarray studies, regrouping
a total of 264 individuals, 21 different radiation doses and 13 different timing points for a total
of 94 data points. Using this approach, we identified 31 genes showing differential expression
in human blood between non-irradiated and irradiated samples, for at least one radiation dose
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in half or more of these studies. The aim of this review is to focus on the identification of
reproducible radiation dosimetry biomarkers. This means the expression level of a gene candi-
date has to be significantly modified after IR but most importantly these changes have to be
dose-dependent. Therefore, we performed a statistical analysis in order to highlight the genes
with the highest correlation between expression level and radiation dose. The top 5 genes are:
TNFSF4, TMEM30A, FDXR, ZMAT3 and AEN.
In order to assess the diagnostic ability of these genes for discriminating radiation doses<
2 Gy and 2 Gy, we also created ROCs. Results showed that TNFSF4, FDXR, MYC, ZMAT3
and GADD45A are the top 5 genes with the highest Youden’s index suggesting they have the
most robust discriminating power. When sensitivity is fixed at 100% in order to decrease the
number of false negatives, although results differed, TNFSF4, FDXR and ZMAT3 still have a
good performance score. Although ZMAT3 has been less studied, TNFSF4 and FDXR are
known to be radiation-responsive and are often used in candidate gene approaches and valida-
tion panels [58–63]. Recently, a study provided an in vivo dose-response of the FDXR gene,
both for very low doses or partial body exposure, showing good correlation between physically
and biologically assessed doses, thus confirming the great potential of this gene as candidate
radiation dosimetry biomarker [64]. Moreover, these genes satisfied inter-laboratory compari-
sons that demonstrated that the dose estimates are always comparable, irrespective of the
approach chosen by the different labs, suggesting that the results are independent from the
protocol for preserving blood during incubation times [65].
Although these genes are promising individually, we next investigated combinations of
gene biomarkers in order to improve their performance. As such, we showed that 12 different
combinations of three genes display an AUC equal to 1 suggesting they are able to discriminate
radiation doses < 2 Gy and 2 Gy with 100% accuracy. However, such a score has to be taken
carefully. Even by compiling several studies, our panel is still small for large validation and we
noticed that the best score was obtained with genes having few data points. This suggests that
an increase of sample numbers is likely to decrease diagnostic accuracy and, therefore, a signa-
ture with a larger number of genes may be required to keep the same level of performance.
Nevertheless, as radiation response is complex, this approach confirmed the need for combina-
tions instead of individual biomarkers.
All the studies selected for this review used microarray and therefore, candidate gene have
been identified using this approach. The successful implementation of DNA microarray tech-
nologies requires the development of methods and techniques for the fabrication of microar-
rays, the selection of probes to represent genes, the quantification of hybridization, and data
analysis [66]. The probe set definition issue is particularly of critical importance, as it can dra-
matically influence the interpretation and understanding of expression data derived from
microarray experiments [67]. As such, it is necessary to clearly know the probe sequence in
order to be certain of which gene we identified, but especially which isoform, as several probes
can be used for a same gene. Therefore, particular attention has to be taken in results interpre-
tation and data extrapolation, thus highlighting the importance of validation step by using
gold-standard method such as qRT-PCR. This also highlights the need to optimize the assay
and probe design to the end platform that will be ultimately used during a real scenario.
If a good biodosimetry marker panel needs to be dose-dependent, conversely it should not
be responsive to other stresses like chemical or biological agents. For example, sex and smok-
ing status do not seem to influence the prediction of radiation dose [33], although the radiation
response of some genes could be affected by sex [68]. Most of the studies in our survey have
been performed on healthy individuals. However, Someya et al. showed that miR-99a overex-
pression by 93% or more after irradiation was associated with an elevated incidence of rectal
bleeding, suggesting the radiation-induced overexpression of this biomarker could differ with
A systematic review of gene radiation dosimetry markers in human blood
PLOS ONE | https://doi.org/10.1371/journal.pone.0198851 June 7, 2018 18 / 26
individual radiosensitivity. This highlights the difficulty of defining a threshold as a unique ref-
erence for gene expression level and the necessity to combine several biomarkers assays. Ide-
ally, a biodosimetry signature should be a universal panel with stable expression throughout
the time of interest, say 1–7 days. Our results showed the expected variations in gene response
according to time after exposure thus highlighting again the importance of choosing candidate
dosimetry biomarkers taking such factors into account. For example, even if some genes do
not display the best correlation, they should be preferentially selected and combined in a signa-
ture if they show prolonged temporal stability rather than a gene with better performance
but not reliable over time. Moreover, each radiological disaster being different, radiation
dosimetry markers must also be characterized for the detection of radiation dose from differ-
ent particle types and from a broad range of energies from 10’s of keV to 100’s of MeV. Thus, a
radiation dosimetry biomarker has to be radiation-responsive with different radiation qualities
and dose rates. Studies on normal tissue and cell lines showed that diverse transcriptional pro-
grams in cellular response mechanisms, and involved in the development of normal tissue
damage, may be differentially affected by high and low linear energy transfer (LET) radiation
[69,70]. Such studies inevitably suggest that gene expression could be different in function of
the radiation quality. We saw in this review that most of the genes respond to both X-rays (low
LET) and particles (high LET) and that the fold-change observed in response to particle irradi-
ation is generally greater than the same dose of X rays. However, the variability of response to
different qualities of radiation still remain largely unknown [71] as few studies have deeply
investigated the effects of particle radiation or different dose rates, and additional information
is needed to understand the impact of these parameters on biomarkers. Therefore, current
data do not allow extrapolation of results or claims that such biomarkers can be applied for all
types of situation or stimuli. In many case of radiation exposure, radiation does not occur
alone and modulation of gene expression can be influenced by several confounding factors.
For example, gene expression changes observed during spaceflight may not be only due to IR
but by microgravity, sleep deprivation, isolation, etc., [72]. Changes observed during radiation
treatment may also be influenced by chemotherapy [73,74]. The majority of the studies
included in this review analyzed gene expression in blood from healthy donors after ex-vivo
irradiation and, therefore, exclude such variables. As such, additional studies are required to
investigate the effects of such parameters in establishing a universal biodosimetry gene
signature.
Gene biomarkers may be a reliable assay to assess absorbed radiation dose. However, due to
the multiple approaches and different protocols, results are not always consistent, making it
difficult to highlight the best candidate(s). Therefore, we have compiled results from several
microarray studies in order to highlight the most promising gene biodosimetry markers in
human blood. However, even with such an approach, results cannot be clearly extrapolated.
Recently, a study demonstrated a new method for identifying radiation dosimetry biomarkers
across independent studies by developing a meta-analysis using eleven microarray datasets
[40]. The authors identify 29 gene biomarkers for predicting high (>8Gy) and low (<2Gy)
radiation exposure. Among these 29 biomarkers, only five genes are in common with our
selection (AEN, FDXR, PLK2, RPS27L and SESN1) demonstrating the extreme data heteroge-
neity and the difficulty of analysis to provide a consistent biodosimetry signature. However,
we did not focus our analysis on radiation doses superior to 8 Gy, and among the 51 biomark-
ers discriminating only the lower doses that they identified, fifteen genes are in common with
our selection (AEN, CDKN1A, DDB2, FDXR, GADD45A, MDM2, MYC, PLK2, RPS27L,
SESN1, TIGAR, TNFRSF10B, TNFSF4, TRIAP1 and TRIM22). In order to avoid selection
bias, we chose to focus only on large-scale studies to identify promising radiation dosimetry
biomarkers. Our literature search only identified microarray studies that fit our criteria. To
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our knowledge, no studies investigating gene expression after irradiation in human blood have
so far used other large-scale approaches such as RNA-sequencing, although several studies
have reported radiation-induced gene expression changes in cell lines by using RNA-seq
approach [75,76]. Because of its high efficiency to determine the dynamics of the transcrip-
tome compared to microarray approach [77], this method will probably continue to develop
for the analysis of radiation-induced transcriptome changes in the next years.
Finally, this review focused on the expression of protein-coding genes in blood, but some
studies also investigated other types of radiation biomarkers or other biofluids. Thus, gene
expression changes in saliva have been assessed during radiation treatment for head and neck
cancer [78]. Radiation-induced changes in non-coding RNAs such as miRNAs or recently dis-
covered lncRNAs have also been investigated as potential radiation dosimetry biomarkers
[79–84]. Since new “omics” approaches open the era of big data in biomarker discovery, large-
scale proteomics studies have also been used to identify radiation biomarkers in blood [85,86],
saliva [87] or even urine [88–90]. Metabolomics is also an emerging field to detect changes in
metabolite expression during disease state or after stress induction. Thus, some metabolomics
studies have investigated radiation-induced changes in metabolites expression in saliva [91] or
urine [92–98] to provide an alternate approach for identifying new candidate biodosimetry
markers. These different approaches pave the way to additional studies investigating the com-
bination of several screening methods as a good alternative to study interactions between dif-
ferent molecular entities and highlight major pathways involved in radiation response in order
to identify new radiation biomarkers.
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